The method 9, wherein said oral administration is characterized by {HEAD ~ substantially no increase} in {TAIL ~ serum levels} of aspartate aminotransferase , alanine aminotransferase , or both 
in
The method 9 , wherein said oral administration is characterized by { HEAD ~ substantially no increase } in { TAIL ~ serum levels } of aspartate aminotransferase , alanine aminotransferase , or both
OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD HEAD HEAD REL TAIL TAIL TAIL TAIL TAIL TAIL OTH OTH OTH OTH OTH OTH OTH OTH OTH